Canada Drug-Coated Balloons Market: By Indication (PAD, CAD, others), By Drug Type (Paclitaxel, Sirolimus), By End-user (Hospitals Ambulatory Care Settings, Freestanding Cath Labs)

Canada  Drug-Coated Balloons Market size was valued at USD million in 2021. It is expected to reach USD million by 2028, growing at a CAGR of 11.9% from 2022 to 2028. The market report provides a detailed overview of the market, which can be segmented by indication, drug type, and end-user. By indication, the Canadian drug-coated balloons market has been segmented into PAD, CAD, and others. The PAD segment is likely the most significant and fastest-growing segment regarding VARIOUS indications. The Canada drug-coated balloons market has been segmented by drug type into Paclitaxel and Sirolimus. The Paclitaxel segment accounted for the high revenue share in 2021. Based on end-user, the Canadian drug-coated balloons market is segmented into Hospitals, Ambulatory Care Settings, and Freestanding Cath Labs. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.